Mutations in the MEditerranean FeVer (MEFV) gene are responsible for familial Mediterranean fever (FMF), a recessively inherited auto-inflammatory disease. Cases of dominant inheritance and phenotype -genotype heterogeneity have been reported; however, the underlying molecular mechanism is not currently understood. The FMF protein named pyrin or marenostrin (P/M) is thought to be involved in regulating innate immunity but its function remains subject to controversy. Recent studies postulate that a defect in MEFV expression regulation may play a role in FMF physiopathology. Our group, along with others, has identified several alternatively spliced MEFV transcripts in leukocytes. Since alternative splicing and nonsensemediated decay (NMD) pathways are usually coupled in the post-transcriptional regulation of gene expression, we hypothesized that NMD could contribute to the regulation of the MEFV gene. To address this issue, we examined the effect of indirect and direct inhibition of NMD on expression of the MEFV transcripts in THP1, monocyte and neutrophil cells. We showed that MEFV is the first auto-inflammatory gene regulated by NMD in both a cell-and transcript-specific manner. These results and preliminary westernblot analyses suggest the possible translation of alternatively spliced MEFV transcripts into several P/M variants according to cell type and inflammatory state. Our results introduce the novel hypothesis that variation of NMD efficiency could play an important role in FMF physiopathology as a potent phenotypic modifier.
INTRODUCTION
The name of auto-inflammatory diseases was initially proposed in 1999 by McDermott et al. (1) . This group of disorders includes an expanding number of inflammatory syndromes caused by innate immunity deficiency, distinguishing them from autoimmune diseases which relate to a defect in acquired immunity. Auto-inflammatory diseases are clinically characterized by seemingly unprovoked recurrent bouts of inflammation (2) .
The recessively inherited disease familial Mediterranean fever (FMF, MIM 249100), is the prototype for autoinflammatory diseases. Almost exclusively affecting populations of Mediterranean origin (Arabs, Armenians, Jews and Turks) (3), FMF is characterized by recurring attacks of fever accompanied by serositis, along with a massive influx of neutrophils into the affected tissues.
The MEditerranean FeVer (MEFV) gene on chromosome 16p13.3 was identified by positional cloning carried out by two independent consortia in 1997 (4, 5) . To date, around 70 disease-associated mutations have been identified in MEFV (6), the majority being missense mutations localized in exons 2 and 10. However, an increasing number of patients with clinical FMF have either no, or only one, mutation in the MEFV coding sequence. Three groups searched for mutations outside the MEFV coding sequence, either in the 5 0 -(7) or 3 0 -untranslated region (8) of this gene or in another gene to address the hypothesis of a digenic model (9) . However, this did not yield any definitive conclusions.
The MEFV gene is mainly expressed in neutrophils, monocytes and dendritic cells, and to a lesser extent in eosinophiles and several cell lines (10, 11) . It encodes a 781 amino acid protein named pyrin (5) or marenostrin (4) . Pyrin/marenostrin † The nucleotide sequence data reported in this article have been submitted to GenBank and assigned the accession numbers: FJ785717 (transcript del234) and FJ785722 (transcript 2D/9ext).
(P/M) interacts with several cellular proteins, including the adaptor protein ASC (12) responsible for mediating proteolytic activation of procaspase-1 into caspase-1, thus enabling its involvement in several multiprotein complexes known as inflammasomes [for a review (13) ]. On the basis of both the dramatic inflammatory manifestations of FMF and on recent studies documenting the role of P/M in inflammasome regulation, P/M appears to be a major regulator of inflammation and innate immunity.
The exact role of P/M in innate immunity, particularly in inflammation, is controversial and its involvement in FMF is still under discussion. Notably, both inhibiting (14) and activating (15 -17) functions have been postulated. The amount of MEFV mRNA in peripheral blood leukocytes is significantly lower in FMF patients than in patients with acute appendicitis or controls (18, 19) suggesting that MEFV transcription could be dysregulated in FMF. The MEFV pre-mRNA is also subject to alternative splicing. Along with others, our group has identified multiple alternatively spliced transcripts in peripheral blood leukocytes [(20) ; Grandemange et al., manuscript in preparation and this report], or in synovial fibroblasts (21) . Five major splicing events involving exons 2, 3, 4 or 8 occur in MEFV pre-mRNA ( Fig. 1A and B) .
Alternative splicing can both modify protein structure by deleting or inserting amino acids, and regulate transcript expression levels by directing mRNAs towards nonsensemediated decay (NMD) [for a review (22) ]. To prevent translation of unnecessary and aberrant transcripts or to modulate protein level in a cell specific manner, NMD acts as an mRNA quality control mechanism by detecting and degrading mRNAs comprising a premature terminal codon (PTC). More than one third of physiological alternatively spliced transcripts contain a PTC that triggers the NMD process. Generally, only a PTC situated at most 50-55 nt upstream of the last exonexon junction will trigger NMD, whereas those downstream avoid detection.
Accordingly, alternatively spliced MEFV transcripts containing exons 8ext and 4a and the del234 transcript are potential targets for NMD. However, the possible role of NMD in MEFV gene regulation has yet to be addressed. In this article, we examine whether NMD could regulate the MEFV gene. In order to delineate potentially translated MEFV transcripts, we studied those subject to NMD in THP1, monocyte and neutrophil cells. We show that the three transcripts containing exon 4a and the del234 transcript are degraded by the NMD mechanism in all three cell types, whereas NMD appears only to regulate the 3 0 -8ext amplicon in monocytes. Table S1 ), and the amplified MEFV region is underlined. The stop road signs depict the PTC locations. Each of these three amplicons monitors three different alternatively spliced transcripts (dotted connectors). (C) Separation of the corresponding amplicons on a 5% acrylamide gel demonstrates Q-PCR products of anticipated lengths. cDNAs were amplified from the THP1 cell line, monocytes (Mono.) neutrophils (Neutro.). Control samples (H 2 O; PCR mix free of cDNA) were run in all experiments.
RESULTS

Effect of indirect inhibition of NMD on MEFV transcripts
We developed quantitative PCR (Q-PCR) to test whether alternatively spliced MEFV mRNAs containing a PTC were targeted by the NMD machinery. We designed three pairs of primers (Supplementary Material, Table S1) to yield 3 0 PCR products that we named: 3 0 -full length (FL) (primers spanning the junction of exons 4 -5 to the junction of exons 8 -9), 3 0 -8ext (primers spanning exons 6 -8ext) and 3 0 -4a (primers spanning the junction of exons 4 -4a to the junction of exons 4a -5). MEFV is subject to multiple and complex alternative splicing events [ Fig. 1A and B; (20, 21) , this report] and the basal expression of some transcripts such as del234 is very low. Hence, rather than carry out Q-PCR experiments for each single transcript, we chose these primer pairs to co-amplify three possible cDNA types (Fig. 1B) . We studied MEFV transcripts expressed in THP1, a mononuclear cell line commonly used for functional studies of the P/M protein and the inflammasome, as well as in the more physiological monocyte and neutrophil cells isolated from whole blood in seven healthy volunteers. We observed bands of expected sizes on a polyacrylamide gel for all three cell types (Fig. 1C) , suggesting a 3 0 Q-PCR product specificity which was thereafter confirmed upon sequencing of the extracted bands.
Since NMD degrades mRNA through recognition of the PTC during the initial round of protein translation, it can be reversed upon treatment with protein synthesis inhibitors such as cycloheximide (CHX) (23) . We treated or not each cell type with CHX in the 2 h prior to RNA extraction and measurement of transcript expression levels. As a positive control we quantified the ribosomal protein L3 (RPL3) transcript which is a physiological target of NMD (24) . In THP1 cells, monocytes and neutrophils, the level of RPL3 was significantly up-regulated in the presence of CHX, confirming that NMD inhibition was effective in our experiments ( Fig. 2A -C) . Translation inhibition in the THP1 mononuclear cell line following CHX treatment, showed no effect on the levels of the two MEFV PCR products 3 0 -FL and 3 0 -8ext, corresponding to transcripts containing the 3 0 MEFV constitutive exons and exon 8ext, respectively ( Fig. 2A) , whereas 3 0 -4a, corresponding to transcripts containing exon 4a, was markedly increased (13-fold) (P ¼ 0.005). In monocytes, indirect inhibition of NMD up-regulated 3 0 -8ext and 3 0 -4a levels (1.7-fold; P ¼ 0.03 and 6-fold; P ¼ 0.0005, respectively) but did not affect the level of PCR product 3 0 -FL (Fig. 2B) . In neutrophils (Fig. 2C ), CHX treatment (P ¼ 0.006) led to an increase only in the level of 3 0 -4a. These results led us to hypothesize that in all three cell types the NMD machinery degraded part or all of the MEFV transcripts containing exon 4a, whereas it only degraded those containing exon 8ext in monocytes.
MEFV transcripts containing exon 4a, and not 8ext, are subject to NMD degradation in THP1 cells
Treating cells with the non-specific protein synthesis inhibitor CHX increases the levels of various alternatively-spliced MEFV transcripts, indirectly supporting our hypothesis that they are inhibited by the NMD machinery. To ascertain a true involvement of NMD in regulating levels of MEFV transcripts, we transfected the THP1 cell line with either specific small interfering RNA (siRNA) to silence the NMD complex factor up-frameshift 1 (UpF1) (22) or with nonspecific (Ctrl) siRNA [Fig. 3 (25) ]. We first measured the transcript levels of both UpF1 and RpL3 as a control of the experimental knock-down efficiency. As expected, UpF1 transcript level decreased significantly after UpF1 silencing ( Fig. 3A ; P ¼ 0.0007), whereas RpL3 level increased (P ¼ 0.017). Western-blot analysis ( an effective down-regulation of UpF1 protein by the specific siRNA. Regarding MEFV, only the amplicon containing exon 4a was significantly increased ( Fig. 3B ; P ¼ 0.016), confirming the result obtained in indirect NMD inhibition experiments ( Fig. 2A ). These data provide strong evidence in favor of the NMD machinery regulating transcripts containing exon 4a in the THP1 cell line.
Transcripts 8ext and 2D/8ext may escape NMD degradation whereas NMD degrades all three transcripts containing exon 4a in THP1 cells
The results presented in Figures 2A and 3 demonstrate that transcripts containing exon 4a, and not 8ext, are degraded by the NMD mechanism in THP1 cells. Since each of these two amplicons monitors three different co-amplified cDNA species (Fig. 1B) , we designed new primers (Supplementary Material, Table S1 ) spanning specific exon-boundaries to try to detect a possible differential NMD regulation of each PTC-containing MEFV transcript. Due to the basal level of different transcripts being either very weak or undetectable and/or amplicon size being too large, we were unable to establish reproducible Q-PCR conditions with these specific primer pairs. Thus, we performed classical RT-PCR on THP1 mRNA after siRNA transfection utilizing the beta-2-microglobulin (B2M) transcript. This was one of the three reference genes used in our Q-PCR assays to control for similar cDNA amplification in THP1 cells transfected with Ctrl or UpF1 siRNAs (Fig. 4A ). Direct NMD inhibition by UpF1 siRNA failed to increase 8ext transcript expression (Fig. 4B ), but as its basal expression was very low, it is difficult to definitively rule out NMD regulation of this transcript. Expression of 2D/8ext did not increase in the presence of UpF1 siRNA either, suggesting that it too is not a natural NMD target in THP1 cells. Even after NMD knock-down, expression of 2a8ext was undetectable (data not shown), whereas expression of each of the three transcripts containing exon 4a (4a, 2D/4a and 2a/4a) was markedly enhanced following NMD inhibition (Fig. 4B) , strongly suggesting that all three are natural NMD targets.
Other MEFV transcripts
We also investigated two additional alternatively spliced transcripts harboring a PTC that we had recently identified. We identified the del234 transcript (GenBank accession number FJ785717) while performing a study on MEFV expression in FMF patients and controls (Grandemange et al., manuscript in preparation). In an attempt to clone FL MEFV transcripts, primers spanning exon 1 to exon 10 were designed to amplify the entire coding sequence of mRNAs from a control individual using RT -PCR. This experiment enabled us to identify isoform 2D/9ext (GenBank accession number FJ785722) which includes an in-frame deletion of exon 2 and a 5 0 177 bp extension of exon 9 leading to a PTC in exon 9 (Fig. 4C) . The basal 2D/9ext expression was low and did not appear to increase after NMD inhibition. In contrast, del234 was clearly up-regulated by UpF1 siRNA suggesting its degradation by NMD machinery in THP1 cells.
Protein expression
Our results at the MEFV transcriptional level led us to postulate that some transcripts could potentially generate several proteins in addition to the P/M protein encoded by the consensus mRNA. In an attempt to corroborate this hypothesis, western-blot analysis was performed on total protein extracts from the HEK293 cell line over-expressing specific splice variants, and from THP1 with and without direct NMD inhibition. As shown in Figure 5 , migration of the endogenous protein products detected in THP1 could be compared with three of the specific bands over-expressed by HEK293. The largest protein product (.80 kDa) was compatible with the size of the endogenous P/M, although it was difficult to definitely ascertain this since a non-specific band migrated at the same level in all tracks. However, the two smaller bands obtained were likely to be the isoforms expressed by the 2D8ext and 2a4a splice variants. In agreement with the results obtained at the transcriptional level (Fig. 4) , the putative 2D8ext was insensitive to NMD whereas expression of the putative 2a4a was increased after direct inhibition of NMD (Fig. 5) .
DISCUSSION
A growing body of evidence suggests that a defect in MEFV expression regulation likely plays a role in the pathophysiology of FMF (8, 9, 18, 19) . Here, we have investigated the possible post-transcriptional regulation of the MEFV gene by NMD. On the basis of the '50 -55 nt' rule, MEFV transcripts containing exons 8ext, 4a, 9ext and the del234 transcript were considered potential NMD targets. To test this hypothesis, we performed a quantitative analysis of mRNA expression in MEFV expressing cells subjected or not to NMD inhibition.
As expected, expression of the 3 0 -FL amplicon, corresponding to transcripts FL, 2D and 2a (Fig. 1B) which do not contain a PTC, was insensitive to NMD down-regulation in THP1 cells, monocytes and neutrophils (Figs 2 and 3) . In contrast, Q-PCR (Figs 2 and 3 ) and RT -PCR analyses (Fig. 4B) showed that the three MEFV transcripts containing exon 4a were physiological targets of NMD in all three cell types. Although the del234 spliced transcript was undetectable by RT-PCR on cDNAs from THP1 cells (Fig. 4C) , direct inhibition of NMD induced its expression. Altogether, these data suggest that transcripts harboring a PTC in exon 5 are degraded by NMD and thus are probably not translated into protein in these cells.
The case of the 3 0 -8ext amplicon is intriguing. Whereas it is not degraded by NMD in THP1 and neutrophil cells, its expression is up-regulated in monocytes following NMD inhibition (Figs 2 and 3 ). This result raises several interesting issues: (a) the cell specificity of NMD regulation of MEFV; (b) the potential absence of compliance to the rule of '50 -55 nt' in PTC-bearing transcripts containing exon 8ext, at least in THP1 and neutrophil cells; (c) the potential translation of some of the corresponding transcripts into functional protein in a cell-specific manner.
Several teams have reported on the tissue or cell specificity of NMD [for review (22) ]. To our knowledge, the effect of NMD on gene expression has never been studied in monocytes or neutrophils. Our results strongly suggest that at least some of the transcripts containing exon 8ext can be specifically degraded by NMD in monocytes but not in neutrophils. As THP1 is a mononuclear cell line, we expected to observe similar results in monocytes. Such cell-specific differences have already been shown in previous work on the related protein cryopyrin or NLRP3 (26) . Whereas three forms of this inflammasome component were shown to be strongly expressed in THP1 cells, only the shortest one was detected at a very low level in monocytes. Diaz et al. (21) , who identified the transcripts containing exon 8ext, did not study their expression in THP1 cells. They did, however, show that in whole peripheral blood leukocytes, 2D/8ext was far less expressed than the 8ext transcript, contrasting with our results in THP1 cells (Fig. 4B) . We therefore postulate that regulation of transcripts containing 8ext is highly cell-specific. Cell specificity of NMD has been suggested in another cellular model (27) , however, the mechanism involved remains to be determined.
Our results demonstrate that PTC-bearing transcripts containing exon 8ext do not follow the NMD '50 -55 nt' rule in THP1 and neutrophil cells, and 2D/9ext seems to be similarly insensitive in THP1 cells (Fig. 4C) . Although 2D/8ext (21) contains a 5 0 sequence of intron 8, 2D/9ext contains a 3 0 sequence of intron 8. It is interesting to note that these two transcripts are derived from a close splicing event and both appear insensitive to NMD in THP1 cells. Alternative expected pathological (28) or normal (29) NMD substrates have been reported to also be NMD insensitive. The mechanism by which stop codons are defined as premature or natural remains unclear. Recent studies revealed that 3 0 -UTRs and mRNA secondary structure can also influence PTC recognition in human cells (30) . On the other hand, in THP1 cells we cannot rule out the possibility that NMD regulation is less effective in transcripts containing exons 8ext and 2D/ 9ext than in those containing exon 4a.
Overall, our data strongly suggest that the 2a, 2D, 8ext, 2D/ 8ext and 2D/9ext MEFV transcripts could potentially generate several proteins in addition to the P/M protein encoded by the consensus mRNA. Two proteins translated from alternatively spliced transcripts have been detected in the mouse (31) making it reasonable to predict the existence of several such human proteins. This hypothesis seems to be confirmed by our preliminary study on protein expression in the THP1 cell lines (Fig. 5) . Using western-blot analysis, we indeed identified two P/M isoforms shorter than the predicted protein translated from the FL transcript: these may correspond to 2D8ext and the smallest to the 2a4a isoform. Interestingly, the expression level of these two P/M isoforms was consistent with the NMD inhibition effect observed at the cDNA level. The sequence homology between human MEFV genes and the mouse ortholog is particularly weak in exon 2 and differs in the exon structure of the 3 0 gene region (32) . Interestingly, these two regions are alternatively spliced in humans and contain the major FMF mutations. The predicted 8ext, 2D/8ext and 2D/9ext human proteins all lack the B30.2 domain encoded by human exon 10, as seen in mouse pyrin. We postulate that alternative splicing and NMD pathways are linked in the post-transcriptional regulation of the MEFV gene, generating protein isoforms with biological properties that differ in protein -protein interaction, sub-cellular localization or inflammatory function. This attractive hypothesis is supported by the controversial results of functional or subcellular localization studies. For example, protein isoforms containing an in-frame deletion of exon 2 (20, 21) localize in the nucleus, whereas all other isoforms are cytoplasmic. Diaz et al. (21) showed that endogenous P/M was predominantly cytoplasmic in monocytes, but nuclear in neutrophils. Confirmation of our hypothesis would provide a new level of complexity in the understanding of normal regulation of the P/M inflammatory pathway.
Altered regulation of MEFV gene expression has already been implicated in FMF pathophysiology (8, 9, 18, 19) . To date, one dominantly inherited nonsense MEFV mutation (Y688X) has been reported (33) that may be insensitive to NMD due to its location in exon 10. Indeed, variation in NMD efficiency has been associated with numerous genetic disorders [for reviews (34, 35) ] with NMD acting as a potent phenotypic modifier, for example during the search for the cause of unusual dominant mode of inheritance (36) as seen in beta-thalassemia (MIM 141900), or of the broad intrafamilial and interfamilial clinical variability (37) seen in Roberts syndrome (MIM 268300). Moreover NMD can control responsiveness to treatment in patients with cystic fibrosis (MIM 219700) (38) . We propose that interindividual variations in NMD efficiency on alternatively spliced MEFV transcripts could lead to modulated MEFV expression and thereby account for part of the phenotypic heterogeneity observed in FMF patients (39) , or even in some cases of inherited dominance (33) .
In conclusion, our results declare MEFV to be the first autoinflammatory gene regulated by NMD, and suggest that several protein isoforms encoded by transcripts 2a, 2D, 8ext, 2D/8ext and 2D/9ext could exist in leukocytes alongside the regular P/M protein, with likely different sub-cellular localizations and inflammatory functions. NMD may therefore be used to adapt protein expression as per the physiological needs of the cell and could be at least partly responsible for the clinical heterogeneity observed among FMF patients.
MATERIALS AND METHODS
Cell culture
The THP1 mononuclear cell line was grown in complete RPMI 1640 medium (Gibco w Invitrogen, Cergy Pontoise, France) containing 10% (v/v) heat-inactivated fetal bovine serum (Invitrogen, Cergy Pontoise, France), 50 mM betamercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin/ streptomycin and 1 mM Hepes buffer (Sigma-Aldrich, S T Quentin, France).
Blood from seven healthy volunteers was collected in tubes containing heparin and pooled for cell separation. Pooled blood was diluted in RPMI (1:1), layered over one volume of lymphocyte separation medium (Eurobio, Courtaboeuf, France; density 1.077 + 0.001), and centrifuged at 400g for 30 min at room temperature. Mononuclear cells were obtained from the highest band and washed twice with phosphate buffer saline (PBS). Monocytes were separated from the mononuclear cell fraction by culture onto plastic cell-culture dishes for 2 h. Adhered cells were then washed twice in PBS and counted. These cells were confirmed as monocytes from their morphology after coloration with May-Grünwald's eosine-methylene modified blue solution (Merck, Lyon, France). Neutrophils were purified from the pellet by lysis of red cells with blood lysis buffer containing 155 mM NH 4 Cl, 10 mM KHCO 3 and 1 mM EDTA (10 min at room temperature). After centrifugation (10 min at 500g), cells were washed twice with blood lysis buffer and counted.
Viability of the cells were tested by acridine orange/ethidium bromide staining (40) . Monocytes and neutrophils were grown in RPMI 1640 containing 10% (v/v) heat-inactivated fetal bovine serum, 2 mM L-glutamine and 100 U/ml penicillin/streptomycin.
The human epithelial kidney cell line 293 (HEK293), that does not express MEFV, was used to generate positive controls of the various protein isoforms for western-blot analysis. HEK293 cells were grown in complete DMEM medium (Gibco w Invitrogen, Cergy Pontoise, France) containing 10% (v/v) fetal bovine serum (Invitrogen, Cergy Pontoise, France), 2 mM L-glutamine and 100 U/ml penicillin/streptomycin.
Indirect and direct inhibition of NMD
We first used CHX, a general protein translation inhibitor, to investigate if MEFV transcripts were subject to regulation by NMD. THP1, monocyte and neutrophil cells were cultured in 12-well plates at a density of 10 6 cells/ml. Incubations were performed at 378C in a humidified atmosphere containing 5% CO 2 in air, in the presence or absence of 200 mg/ml CHX solution (US Biological Massachusetts, USA) for 2 h prior to RNA extraction.
We also directly inhibited NMD by silencing UpF1 expression using the siRNA oligonucleotide THP1 cells plated into a 24-well plate at a density of 3 Â 10 5 cells/ml in serum-free medium OptiMEM (Gibco w Invitrogen, Cergy Pontoise, France) were transfected with 40 pmol siRNA using 1.6 ml Lipofectamine 2000 (Invitrogen Cergy Pontoise, France). After 8 h, the medium was replaced by a complete RPMI 1640 medium without antibiotics and the cells were further grown for 64 h prior to RNA extraction. The protein analysis experiment was carried out in 100 mm dishes using the same conditions as for RNA extraction but with thirty times more cells, medium and amounts of siRNA and lipofectamine 2000.
RNA extraction and reverse transcription
Total RNA was extracted using the RNeasy w Mini Kit (Qiagen SA, Courtaboeuf, France) according to the manufacturer's instructions. One microgram total RNA was denatured for 10 min at 708C, then reverse-transcribed into cDNAs in a total volume of 25 ml containing 0. 
Quantitative PCR
A LightCycler-based real-time PCR assay was developed to quantify the 3 0 -FL, 3 0 -4a and 3 0 -8ext MEFV amplicons (Fig. 1B) . Reaction mixtures (10 ml) contained SYBR-Green I mixture (Roche diagnostics, Mannheim, Germany), 200 -300 nM of forward and reverse primer (Supplementary Material, Table S1 ), and standardized dilutions of all cDNA samples that were chosen to remain within the limits of the PCR standard curve.
The initial 10 min denaturing phase at 958C was followed by 45 cycles at 958C for 10 s, at an annealing temperature specific to each primer pair for 10 s, then at 728C for a length of time specific to each primer pair (Supplementary Material, Table S1 ). At the end of the PCR, the temperature was increased from 55 to 958C at a ramp rate of 48C/min, and the fluorescence was measured every 10 s to construct the melting curve. Each assay included in duplicate a negative control free of cDNA and a 3-fold dilution cDNA series to generate a standard curve and calculate the amplification efficiency. All other samples were analyzed in triplicate to check for reproducibility. Q-PCR products were separated by electrophoresis on a 5% acrylamide gel, stained with ethidium bromide (Fig. 1C ) and the specificity checked by sequencing of extracted bands on an ABI Prism 3130 genetic analyzer.
The threshold cycle (Ct) values obtained from the Lightcycler w 480 Relative quantification Software (Roche diagnostics, Mannheim, Germany) were exported to Qbase (41), a Microsoft Excel application that applies Visual Basic VBA codes. Qbase performs relative quantification from the standard curve using a modified delta-Ct method that integrates adjustment for PCR efficiency and use of multiple reference genes for normalization of the relative quantification (see also geNorm manual, http://medgen.ugent.be/genorm). Here, to achieve more accurate and reliable results we used three reference genes with early (Actin-beta, ACTB), medium (beta-2-microglobulin, B2M) and late (TATA box binding protein, TBP) Ct. to have the same interval of Ct values between references genes and our different samples and amplicons.
Polymerase chain reaction
RT-PCR was developed to specifically detect one MEFV transcript at a time. The cDNA (1/25 of the reverse transcription reaction) was amplified with Taq Gold DNA polymerase (Applera France SA, Courtaboeuf, France). The reaction mixtures were incubated in a thermocycler GeneAmpPCR System 2700 (Applera France SA, Courtaboeuf, France) under the following conditions: 1 cycle of 10 min at 958C followed by several cycles (specific of each amplicon, see Supplementary Material, Table S1 ) each consisting of 30 s at 958C, 45 s at a specific temperature annealing (Supplementary Material, Table S1 ), and 1 min at 728C, followed by 1 cycle of 7 min at 728C. The amplified products were separated by electrophoresis on a 5% acrylamide gel and stained in ethidium bromide. Amplification of B2M transcript was used throughout as a positive control for successful amplification of cDNAs.
Construction of MEFV recombinants and cellular transfection
Primers were designed to clone FL MEFV and the alternatively spliced MEFV transcripts using RT -PCR from individual controls (Supplementary Material, Table S2 ). The PCR products were directly cloned into per 2.1-TOPO vector according to manufacturer's instructions (Invitrogen, Cergy Pontoise, France) and sequenced. This RT -PCR identified two novel MEFV transcripts: del234 (GenBank accession number FJ785717) and 2D/9ext (GenBank accession number FJ785722).
The FL and 2D transcripts were digested with EcoRI and XhoI and the 2a4a and 2D8ext cDNAs with EcoRI. The digested products were inserted into the corresponding sites of the mammalian expression vector pcDNA3 (Invitrogen Cergy Pontoise, France). The 8ext construct was derived from 2D8ext vectors using the same KpnI strategy as described in Diaz et al. (21) . All recombinants were checked by sequencing.
The HEK293 cell line was used to over-express either of the MEFV cDNA species. The cells plated into a six-well plate at a density of 9 Â 10 5 cells/ml in serum-free medium OptiMEM (Gibco w Invitrogen, Cergy Pontoise, France) were transfected with 4 mg of pcDNA3 expression vector using 7.5 ml Lipofectamine 2000 (Invitrogen Cergy Pontoise, France). After 4 h, the medium was replaced by a complete DMEM medium without antibiotics and the cells were further grown for 20 h prior to protein extraction.
Cell lysate and western-blot analysis
After transfection, the HEK293 and THP1 cells were washed and lysed in 100 ml of lysis buffer (20 mM Tris-HCl pH7.5, 0.4 M KCl, 20% glycerol, 2 mM DTT) supplemented with 1Â protease inhibitor cocktail (Roche diagnostics, Mannheim, Germany) and 1 mg/ml pefabloc (Roche diagnostics, Mannheim, Germany) on ice for 20 min. After three freezing-thawing cycles in nitrogen liquid-ice, cell debris was removed by centrifugation at 15 700 g at 48C for 10 min. The protein concentrations were determined using the coomassie protein assay kit (Pierce, Rockford, USA) according to the manufacturer's instructions. Adjusted amounts of protein extracts were resolved on an 8 or 10% SDS-PAGE gel to analyze hUPF1 or P/M expression, respectively, and transferred to a PVDF membrane (Polyvinylidene fluoride, Millipore, Billerica, USA). The membrane was probed with the appropriate primary antibody in PBS 1Â (Gibco w Invitrogen, Cergy Pontoise, France) containing 0.2% Tween (PBST) with 3% non-fat dry milk, then with the peroxidase conjugated secondary antibody. For hUPF1 detection, we used 500Â dilution of Rent1 (P-14) antibody (Santa Cruz Biotechnology Inc., California, USA) and donkey anti-goat IgG-HRP secondary antibody (Jackson ImmunoResearch, Suffolk, UK). For actin detection we used 1000Â dilution of rabbit anti-actin antibody (Sigma-Aldrich, S T Quentin, France) and goat anti-rabbit IgG-HRP secondary antibody (Jackson ImmunoResearch, Suffolk, UK). For P/M detection, the membrane was probed with a 1000Â dilution of goat anti-MEFV antibody (EverestBiotech, Oxfordshire, UK) and rabbit anti-goat IgG-HRP secondary antibody (EverestBiotech, Oxfordshire, UK).
Statistical analysis
The two-tailed Student's t-test was used to evaluate the differences between the normalized relative quantities of MEFV amplicons. Values are expressed as mean + SEM. Values of P , 0.05 were considered statistically significant.
